COMPREHENSIVE CLASS IMBALANCE STRATEGY COMPARISON - V5 (FULL DATA)
========================================================================================================================

Dataset: 3107 samples (FULL)
Class distribution: I=892, P=1880, R=335
Imbalance ratio: 5.6:1
Cross-validation: 3-fold patient-level CV
Runtime: 5.7 minutes

Baseline: F1m=0.3640, F1w=0.5238, MinF1=0.0945, κ=0.0768, BA=0.3781

RESULTS (sorted by avg improvement):
------------------------------------------------------------------------------------------------------------------------
2. RandomOverSampler: avg_imp=+73.7%, F1m=0.4436, MinF1=0.2808, κ=0.1719
17. SMOTE+Alpha(sqrt): avg_imp=+67.3%, F1m=0.3967, MinF1=0.3142, κ=0.1416
9. Alpha (balanced): avg_imp=+65.9%, F1m=0.4204, MinF1=0.3067, κ=0.1353
6. Borderline-SMOTE: avg_imp=+61.3%, F1m=0.4171, MinF1=0.2975, κ=0.1259
16. Oversample+Alpha(sqrt): avg_imp=+59.9%, F1m=0.3865, MinF1=0.2829, κ=0.1426
12. Oversample+Alpha: avg_imp=+59.5%, F1m=0.3948, MinF1=0.3110, κ=0.1190
5. ADASYN: avg_imp=+57.7%, F1m=0.4216, MinF1=0.3064, κ=0.1034
11. Focal Loss: avg_imp=+56.4%, F1m=0.4122, MinF1=0.2654, κ=0.1349
4. SMOTE: avg_imp=+55.4%, F1m=0.4148, MinF1=0.2686, κ=0.1263
3. RandomUnderSampler: avg_imp=+53.9%, F1m=0.4047, MinF1=0.2892, κ=0.1102
7. SMOTE+Tomek: avg_imp=+52.9%, F1m=0.4200, MinF1=0.2514, κ=0.1296
8. SMOTE+ENN: avg_imp=+47.7%, F1m=0.3650, MinF1=0.2794, κ=0.1113
18. SMOTE+Tomek+Alpha: avg_imp=+44.4%, F1m=0.3653, MinF1=0.2737, κ=0.1040
15. SMOTE+Focal: avg_imp=+42.7%, F1m=0.3460, MinF1=0.2448, κ=0.1275
13. SMOTE+Alpha: avg_imp=+40.7%, F1m=0.3635, MinF1=0.2498, κ=0.1113
14. Oversample+Focal: avg_imp=+32.0%, F1m=0.3421, MinF1=0.2129, κ=0.1162
10. Alpha (sqrt): avg_imp=+6.7%, F1m=0.3778, MinF1=0.1178, κ=0.0811


TOP 3:

1. 2. RandomOverSampler - +73.7% avg improvement

2. 17. SMOTE+Alpha(sqrt) - +67.3% avg improvement

3. 9. Alpha (balanced) - +65.9% avg improvement
